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Introduction
A DNA double strand break (DSB) is a significant lesion and ac-
tivates a DNA damage response (DDR), which encompasses a com-
plex network of proteins that collectively function to enhance survival
and maintain genomic stability. The DDR encompasses pathways of
DSB repair and a signal transduction response that effect cell cycle
checkpoint arrest and apoptosis.1 After induction of DSBs, ataxia
telangiestasia mutated (ATM) phosphorylates H2AX, which occurs
over megabase-pair regions surrounding the DSB. ATM dependent
signalling functions to change the chromatin structure and helps the
recruitment and/or maintenance of mediator proteins, such as MDC1,
53BP1 and BRCA1. 2-5 The G2/M checkpoint is important for the
maintenance of genomic stability by preventing the entry of cells with
unrepaired DSBs into mitosis. ATM establishes the G2/M checkpoint
machinery within 1-2 hr post ionizing radiation (IR). Activated ATM
leads to phosphorylation of Chk1/2 in G2 phase, followed by the
inhibition of Cdc25 activity, which is the phosphatase that regulates
mitotic entry.6 Chk2 is a direct target of ATM whilst Chk1, a sub-
strate of ATR, is indirectly activated following ATM-dependent DSB
resection.7 Therefore G2/M arrest of irradiated G2 phase cells via
either Chk1 or Chk2 is ATM-dependent. Although much is known
about the mechanism leading to activation of G2/M checkpoint ar-
rest, few studies have addressed how arrest is maintained. We re-
cently showed that the duration of arrest is dependent upon the dose
and repair capacity post IR. 8 Further we observed that checkpoint ar-
rest is maintained until the defined threshold of DSBs is reached.
Therefore it is likely that the checkpoint signaling machinery from
unrepaired DSBs, i.e. ongoing signaling, monitors checkpoint main-
tenance. We have previously found that non-homologous end join-
ing (NHEJ) represents the major DSB repair mechanism in G1 and
G2.9,10 We have recently found that only 15~20 % of IR induced
DSBs undergo resection in G2 and processing by homologous re-
combination (HR), and that these represent DSBs repaired with slow
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The G2/M checkpoint is important in preventing cells with unrepaired DNA double strand breaks (DSBs) entering mitosis, an event which is
likely to result in genomic instability. We recently reported that checkpoint arrest is maintained until close to completion of DSB repair and that
the duration of checkpoint arrest depends on the dose and DSB repair capacity rather than lasting for a fixed period of time. ATM leads to
phosphorylation of Chk1/2 in G2 phase following exposure to ionizing radiation. These transducer kinases can phosphorylate and inhibit Cdc25
activity, which is the phosphatase regulating mitotic entry. In this study we dissect three processes that contribute to the maintenance of check-
point arrest in irradiated G2 phase cells. First, the ATR-Chk1 pathway contributes to maintaining checkpoint arrest, although it is dispensable
for the initial activation of checkpoint arrest. Second, ongoing ATM to Chk2 signalling from unrepaired DSBs contributes to checkpoint arrest.
This process plays a greater role in a repair defective background. Finally, slow decay of the initially activated Chk2 also contributes to the
maintenance of checkpoint arrest. 53BP1 and MDC1 defective cells show an initial checkpoint defect after low doses but are proficient in initial
activation of arrest after high doses. After higher radiation doses, however, 53BP1– /– and MDC1–/– MEFs fail to maintain checkpoint arrest.
Furthermore 53BP1– /– and MDC1–/ – MEFs display elevated mitotic breakage even after high doses. We show that the defect in the maintenance
of checkpoint arrest conferred by 53BP1 and MDC1 deficiency substantially enhances chromosome breakage.
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kinetics (Beucher et al, submitted). Here, we investigate the contri-
bution of ongoing signalling and Chk1/Chk2 on the maintenance of
checkpoint arrest and discuss the potential role of mediator proteins
in this process.
Results and Discussion
ATR is required for the maintenance of checkpoint arrest but is dis-
pensable for the initiation of checkpoint arrest
ATM regulates G2/M checkpoint arrest via both Chk2 and Chk1
activation. ATM promotes DNA end resection in G2 phase after IR
and ATR, which is activated by single stranded regions of DNA,
phosphorylates Chk1 at such regions generated by resection. We,
therefore, examined whether the ATR-Chk1 pathway contributes to
the maintenance of checkpoint arrest in irradiated G2 phase cells.
To investigate the contribution of the ATR-Chk1 pathway to the
maintenance of checkpoint arrest, we examined the timing of check-
point release in ATR-Seckel (ATR-SS) cells, which have impaired
ATR function. To examine the maintenance of arrest specifically in
irradiated G2 cell, we added aphidicolin, which is a replication
polymerase inhibitor, to prevent progression of G1 and S cells into
G2 phase during analysis. Interestingly, although G2/M arrest is nor-
mal in ATR-SS hTERT cells following 3 Gy IR, they are released
slightly earlier (4-6 h) than control cells (6-8 h). We recently ob-
served that resected DSBs are repaired by HR with slow kinetics
in G2 phase mammalian cells. Consistent with this observation, the
ATR-Chk1 pathway contributes to the maintenance of checkpoint ar-
rest but is dispensable for initial arrest.
It is likely that the relatively modest contribution of p-Chk1 is con-
sistent with the recent evidence that only ~15 % of IR induced DSBs
undergo resection. However, the contribution of Chk1 activation might
have a greater role in situations where resection occurs but HR fails
(eg BRCA2– /– cells).
Ongoing ATM signalling contributes to the maintenance of check-
point arrest
However, ATR-SS hTERT cells initiate checkpoint arrest normally
and maintain arrest for a limited period post irradiation. In mammal-
ian G2 cells, 80~85 % of IR induced DSBs are repaired by NHEJ,
suggesting that DSB ends, which do not undergo resection, activate
Chk2 by ATM. Therefore, we considered that Chk2 might also con-
tribute to the maintenance of checkpoint arrest. Furthermore, we con-
sidered that the initially activated Chk2 and ongoing ATM to Chk2
signalling from unrepaired DSBs might contribute to the maintenance
of checkpoint arrest. To investigate whether ongoing signalling con-
tributes to checkpoint maintenance, we added the ATM specific in-
hibitor, KU55933 (hereafter designated ATMi) at 30 min post IR,
when ATM dependent G2/M checkpoint arrest has been established.
Interestingly, ATMi-treated cells show premature checkpoint release
(4-6 h) compared to control cells (6-8 h) after 3 Gy IR. Indeed, since
the number of unrepaired DSBs at 6 h, the time of checkpoint release,
is greater in ATMi treated versus control cells, the impact of ongoing
ATM signalling is more marked than apparent from the comparison
with control cells. Importantly ATMi-treated ATR-SS cells show very
early checkpoint release (at 2-4 h), suggesting that both Chk1 and
ongoing ATM to Chk2 signalling contribute to the checkpoint main-
tenance. In contrast, to examine the impact of loss of Chk1/2 activ-
ity, we added SB218078, a Chk1 and Chk2 inhibitor at 30 min post
IR. In the presence of the inhibitor, cells are released earlier than
ATMi-treated ATR-SS cells, suggesting that residual Chk1/Chk2
activity remains and/or that the initially activated Chk2 contributes
the maintenance of checkpoint arrest (see below).
Ongoing ATM signalling plays a significant role in a repair defec-
tive background
NHEJ defective cells show a substantial DSB repair defect in G2
phase as well as in G1 and prolonged checkpoint arrest. We there-
fore considered that ongoing signalling from unrepaired DSBs might
have a greater role in maintaining checkpoint arrest in a NHEJ de-
fective background. To examine this possibility, we carried out the
checkpoint maintenance assay in 2BN hTERT cells, which are de-
fective in XLF/Cernunnos, a core NHEJ component. As expected,
2BN hTERT cells show substantially reduced DSB rejoining in G2
phase confirming that NHEJ is the major DSB repair process in G1
and G2. Then we tested the impact of loss of ongoing signalling in
2BN cells by adding ATMi at 30 min post IR. Interestingly we ob-
served premature release at 4-6 h in ATMi-treated 2BN cells. In
contrast, cells are arrested for >12 h in the absence of ATMi. Thus,
ongoing ATM signalling plays a significantly greater role in main-
taining checkpoint arrest in a repair defective background.
Ongoing ATM signalling is required for maintaining the levels of
phosphorylated Chk2
To investigate the impact of ongoing ATM to Chk2 signalling to
the maintenance of checkpoint arrest, we quantified the levels of
phosphorylated Chk2 (p-Chk2) by immunofluorescence (IF) specifi-
cally in G2 phase. G2 phase cells were identified by CENPF stain-
ing. To confirm antibody specificity of p-Chk2, we measured the
levels of p-Chk2 in Chk2 knockdown cells. Since Chk2 knockdown
cells show significantly reduced p-Chk2 levels, we concluded that p-
Chk2 antibody specifically recognizes phosphorylated Chk2 by IF.
Consistent with the DSB repair defect in 2BN cells, we observed
that the p-Chk2 signal in 2BN cells at 30 min post IR is greater
than in control cells and that it remains elevated for up to 8 hr. After
addition of ATMi at 30 min post IR, p-Chk2 levels decrease dramati-
cally in 2BN cells. These results suggest that ongoing ATM to Chk2
signalling maintains p-Chk2 levels in control cells, and more strik-
ingly in a NHEJ defective background.
The initially activated p-Chk2 decays slowly
Since, in the presence of Chk1/Chk2 inhibitor, cells are released
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earlier than ATMi-treated ATR-SS cells, we considered that the ini-
tially activated p-Chk2 might maintain checkpoint arrest for several
hours. To examine this quantitatively, we measured the p-Chk2 lev-
els by immunoblotting in irradiated G0/G1 cells (used to eliminate
the impact of newly generated DSBs in S phase). As in the check-
point experiment, we added ATMi at 30 min post IR. In the pres-
ence of ATMi, the level of p-Chk2 at 1 and 2 h post IR was lower
compared to non-ATMi treated cells but was above background lev-
els, suggesting that the initially activated p-Chk2 also can partially
contribute to the maintenance of checkpoint arrest without ongoing
ATM signalling.
The involvement of 53BP1 and MDC1 in the maintenance of check-
point arrest
In this study, we dissected three processes that contribute to the
checkpoint maintenance. The first is the ATR/Chk1 pathway. The
second is ongoing ATM to Chk2 signalling and this is observed most
strikingly in a NHEJ defective background. And finally, slow decay
of the initially activated ATM signalling. It has been reported that
the loss of mediator proteins such as 53BP1 and MDC1 show a check-
point defect. 3,4 However this defect is only observed after low doses
and not after high doses. Indeed, we observed an initial checkpoint
defect in 53BP1– /– and MDC1– /– MEFs at 1 hr after 1 Gy IR, with
normal checkpoint arrest after 3 Gy IR. Interestingly we found that
53BP1– / – and MDC1– /– MEFs show premature checkpoint release
after 3 Gy IR. Mediator proteins function has been suggested to am-
plify ATM signalling by the retention of repair proteins at the DSB
site. 53BP1 and MDC1 defective cells fail to form foci of p-ATM,
p-Chk2 and BRCA1 at the site of DSB.4,11,12 Therefore it is likely that
mediator proteins are required for ongoing ATM to Chk2 signalling
at the site of unrepaired DSBs. Furthermore, since 53BP1– /– and
MDC1– / – MEFs show a very early checkpoint release compared to
ATMi-treated cells, the mediator proteins might be required for the
activation of Chk1. We also observed increased chromosomal aber-
rations in the mitotic cells of 53BP1– /– and MDC1– /– MEFs, follow-
ing their release from G2/M checkpoint arrest even after high doses.
Therefore, both the maintenance and initiation of checkpoint arrest is
important in preventing chromosome breakage.
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